Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

AKBA

AKBA News

Newswire

10:52

BTIG Reiterates Buy on Akebia Therapeutics with PT Raised to $5

07:17

Akebia Therapeutics: HC Wainwright Raises PT to $6, Maintains Buy Rating

03:48

Q32 Bio Sells Complement Inhibitor ADX-097 to Akebia Therapeutics for Upfront and Milestone Payments.

10:12

U.S. Stocks Dip, Q32 Bio Shares Surge 171% After $12M Deal

08:03

Akebia Therapeutics to participate in Piper Sandler Healthcare Conference.

View More

About AKBA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More